UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (201) 201
life sciences & biomedicine (194) 194
humans (175) 175
gastroenterology & hepatology (125) 125
male (120) 120
middle aged (114) 114
female (110) 110
adult (86) 86
aged (72) 72
antiviral agents - therapeutic use (59) 59
hepatitis c (59) 59
gastroenterology and hepatology (54) 54
hepatitis c virus (51) 51
treatment outcome (46) 46
hepatology (39) 39
drug therapy, combination (38) 38
liver (37) 37
liver cirrhosis (37) 37
hepatitis c, chronic - drug therapy (35) 35
analysis (34) 34
liver transplantation (34) 34
digestive system diseases (31) 31
gastroenterology (31) 31
hepatitis (31) 31
interferon (31) 31
italy (31) 31
virus diseases (31) 31
hepacivirus - genetics (30) 30
antiviral agents (29) 29
care and treatment (29) 29
interferon-alpha - therapeutic use (29) 29
ribavirin - therapeutic use (28) 28
cirrhosis (27) 27
genotype (27) 27
liver diseases (27) 27
abridged index medicus (26) 26
hepatitis b (25) 25
hepatitis c - drug therapy (24) 24
patients (24) 24
virology (24) 24
health aspects (23) 23
antiviral agents - adverse effects (22) 22
infectious diseases (22) 22
ribavirin (22) 22
aged, 80 and over (21) 21
retrospective studies (21) 21
risk factors (21) 21
polyethylene glycols - therapeutic use (20) 20
hepatitis b, chronic - drug therapy (18) 18
rna, viral - blood (18) 18
young adult (18) 18
adolescent (17) 17
genetic aspects (17) 17
multivariate analysis (17) 17
hepatitis c, chronic - virology (16) 16
hepatocellular carcinoma (16) 16
italy - epidemiology (16) 16
time factors (16) 16
transplantation (16) 16
biological response modifiers (15) 15
general & internal medicine (15) 15
hepatitis c - complications (15) 15
immunology (15) 15
infections (15) 15
medicine, general & internal (15) 15
recombinant proteins - therapeutic use (15) 15
hcv (14) 14
liver cirrhosis - virology (14) 14
medical research (14) 14
pharmacology & pharmacy (14) 14
prospective studies (14) 14
surgery (14) 14
viruses (14) 14
antiviral therapy (13) 13
chronic hepatitis c (13) 13
hepacivirus - drug effects (13) 13
hepatitis b virus - genetics (13) 13
microbiology (13) 13
viral load (13) 13
double-blind method (12) 12
drug therapy (12) 12
follow-up studies (12) 12
genotypes (12) 12
medicine, experimental (12) 12
mutation (12) 12
recurrence (12) 12
chronic infection (11) 11
clinical trials (11) 11
genotype & phenotype (11) 11
hepatitis b virus - immunology (11) 11
liver - pathology (11) 11
liver cancer (11) 11
prognosis (11) 11
ribavirin - adverse effects (11) 11
severity of illness index (11) 11
antigens (10) 10
antiviral agents - administration & dosage (10) 10
hepacivirus (10) 10
hepacivirus - isolation & purification (10) 10
hepatitis c - diagnosis (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 08/2016, Volume 375, Issue 7, pp. 631 - 643
In this 12-month, placebo-controlled trial involving patients with primary biliary cholangitis who had an inadequate response to ursodiol, treatment with... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Liver Cirrhosis - etiology | Bile Acids and Salts - blood | Double-Blind Method | Humans | Middle Aged | Liver Cirrhosis, Biliary - drug therapy | Male | Chenodeoxycholic Acid - analogs & derivatives | Bone Density - drug effects | Chenodeoxycholic Acid - adverse effects | Fibroblast Growth Factors - blood | Chenodeoxycholic Acid - therapeutic use | Adult | Female | Aged | Liver Cirrhosis, Biliary - complications | Liver Cirrhosis, Biliary - blood | Alkaline Phosphatase - blood | Pruritus - chemically induced | Clinical trials | Ursodiol | Care and treatment | Usage | Dosage and administration | Cholangitis | Primary biliary cirrhosis | Alkaline phosphatase | Liver diseases | Syngeneic grafts | Liver | Bilirubin | Pruritus | Phosphatase | Patients | Cirrhosis | Allografts | Acids | Fibrosis | Drug therapy | Bile | Liver transplantation | Index Medicus | Abridged Index Medicus | Alkaline Phosphatase | Chenodeoxycholic Acid | Fibroblast Growth Factors | Gastroenterology and Hepatology | Bone Density | drug therapy | chemically induced | complications | Gastroenterologi | drug effects | Liver Cirrhosis | blood | Bile Acids and Salts | etiology | Biliary | analogs & derivatives | adverse effects | therapeutic use
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Index Medicus | Abridged Index Medicus
Journal Article
Journal of gastroenterology, ISSN 1435-5922, 12/2017, Volume 53, Issue 8, pp. 945 - 958
Journal Article
European radiology, ISSN 1432-1084, 09/2017, Volume 28, Issue 2, pp. 506 - 513
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 10/2004, Volume 40, Issue 4, pp. 883 - 891
The effect of lamivudine treatment on the outcome of patients with hepatitis B e antigen (HBeAg)‐negative chronic hepatitis is unclear. In a retrospective... 
Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2010, Volume 138, Issue 2, pp. 682 - 693.e4
Journal Article